Carolyne Zimmermann's most recent trade in 4D Molecular Therapeutics Inc was a trade of 35,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Carolyne Zimmermann | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Carolyne Zimmermann | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) |